Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tremblay

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Nature Cell Biology|January 27, 2015
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasisMiranda Y Fong, Weiying Zhou, Liang Liu, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.
Nature|June 10, 2016
Cold, clumpy accretion onto an active supermassive black holeGrant R Tremblay, J B Raymond Oonk, Françoise Combes, et al.
Journal of Medicinal Chemistry|June 16, 2009
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.
Journal of Medicinal Chemistry|July 22, 2021
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
The Journal of Clinical Investigation|September 9, 2025
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesisThomas Mandel Clausen, Ryan J Weiss, Jacob R Tremblay, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Nature Cell Biology|January 27, 2015
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasisMiranda Y Fong, Weiying Zhou, Liang Liu, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical CandidateCatherine A Evans, Tao Liu, André Lescarbeau, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of IACS-9439, a Potent, Exquisitely Selective, and Orally Bioavailable Inhibitor of CSF1RBarbara Czako, Joseph R Marszalek, Jason P Burke, et al.
Nature|June 10, 2016
Cold, clumpy accretion onto an active supermassive black holeGrant R Tremblay, J B Raymond Oonk, Françoise Combes, et al.
Journal of Medicinal Chemistry|June 16, 2009
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926)Martin R Tremblay, André Lescarbeau, Michael J Grogan, et al.
Journal of Medicinal Chemistry|July 22, 2021
Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) ApoenzymeMatthew M Hamilton, Faika Mseeh, Timothy J McAfoos, et al.
Plos One|June 2, 2021
A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesisMichael I Dorrell, Heidi R Kast-Woelbern, Ryan T Botts, et al.
The Journal of Clinical Investigation|September 9, 2025
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesisThomas Mandel Clausen, Ryan J Weiss, Jacob R Tremblay, et al.
Pageof 31